nittophase hl & nittophase unylinker solid support · about kinovate life sciences, inc....

2
LIFE SCIENCES LIFE SCIENCES • Fully compatible with standard reagents and synthesis conditions • Standard DMT group and deprotecting conditions • Greater than 99% coupling efficiency • 3’-OH oligonucleotides as end-products after cleavage • Compatible with multiple chemistries • Highly competitive cost NittoPhase ® HL & NittoPhase ® UnyLinker Solid Support Superior Universal Supports for Small to Large Scale Oligonucleotide Synthesis Product Overview UnyLinker loaded NittoPhase ® HL & NittoPhase ® Solid Supports for Oligonucleotide Synthesis, derived from integration of ISIS Pharmaceuticals’ UnyLinker technology and Kinovate’s proprietary solid support, have shown a proven track record of outstanding yields and purity as universal supports from lab to commercial scale at a highly competitive cost. Figure 1. Structure of UnyLinker loaded NittoPhase ® Solid Support. Advantages Elimination of the need for multiple succinates Improved oligonucleotide quality Consistency in batch-to-batch quality Reduced cost through streamline of inventory to one solid support Greater simplicity of inventory management & QC Greatly reducing regulatory requirements – no moiety from UnyLinker integrated into API after cleavage Applications Phosphodiester DNA Oligonucleotides Phosphorothioate DNA Oligonucleotides 2’-O-Alkyl Oligonucleotides siRNA Oligonucleotides LNA and other modified Oligonucleotides Labeled Oligonucleotides Figure 2. Proposed mechanism of cleavage reaction.

Upload: others

Post on 24-Sep-2020

27 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: NittoPhase HL & NittoPhase UnyLinker Solid Support · About Kinovate Life Sciences, Inc. Founded in 2004, Kinovate Life Sciences, Inc. has established itself as a leader in the field

L I F E S C I E N C E SL I F E S C I E N C E S

• Fullycompatiblewithstandardreagentsandsynthesisconditions

• StandardDMTgroupanddeprotectingconditions

• Greaterthan99%couplingefficiency

• 3’-OHoligonucleotidesasend-productsaftercleavage

• Compatiblewithmultiplechemistries

• Highlycompetitivecost

NittoPhase®HL&NittoPhase®UnyLinker™SolidSupportSuperior Universal Supports for Small to Large Scale Oligonucleotide Synthesis

ProductOverview

UnyLinker™ loaded NittoPhase®HL & NittoPhase® Solid Supports for Oligonucleotide Synthesis, derived from integration of ISIS Pharmaceuticals’ UnyLinker™ technology and Kinovate’s proprietary solid support, have shown a proven track record of outstanding yields and purity as universal supports from lab to commercial scale at a highly competitive cost.

Figure1.StructureofUnyLinker™loadedNittoPhase®SolidSupport.

Advantages• Elimination of the need for multiple

succinates• Improved oligonucleotide quality• Consistency in batch-to-batch

quality • Reduced cost through streamline of

inventory to one solid support• Greater simplicity of inventory

management & QC• Greatly reducing regulatory

requirements – no moiety from UnyLinker integrated into API after cleavage

Applications• Phosphodiester DNA Oligonucleotides• Phosphorothioate DNA

Oligonucleotides• 2’-O-Alkyl Oligonucleotides• siRNA Oligonucleotides• LNA and other modified

Oligonucleotides• Labeled Oligonucleotides

Figure2.Proposedmechanismofcleavagereaction.

Page 2: NittoPhase HL & NittoPhase UnyLinker Solid Support · About Kinovate Life Sciences, Inc. Founded in 2004, Kinovate Life Sciences, Inc. has established itself as a leader in the field

L I F E S C I E N C E SL I F E S C I E N C E S

www.kinovate.comKinovate Life Sciences, Inc. 501 Via del Monte, Oceanside, CA 92058 Phone: +1-866-258-3221 Fax: +1-760-435-7050

NittoPhase® is a trademark of Nitto Denko Corporation and UnyLinker™ is a trademark of Isis Pharmaceuticals, Inc. © 2015 Kinovate Life Sciences Inc. All rights reserved. The trademarks mentioned herein are the property of Kinovate Life Sciences Inc., or their respective owners. Printed in the USA. KLS F003 0415

Minutes

AU

260

0 5 10 15 20 25

0.010

0.015

0.005

0.020

i)ComparativeSynthesesatLabScale(1mmol)*

ii)CommercialScale(900mmol)*

Minutes

AU

260

0 5 10 15 20 25

0.010

0.015

0.005

0.020

Fig4.IP-HPLCanalysisofcrudeoligonucleotide.

Formoreinformation,[email protected]

ProductFormats

UnyLinker™ loaded NittoPhase®HL & NittoPhase® Solid Supports are available in a wide range of loading levels to meet the full array of oligonucleotide synthesis needs.

Performance

UnyLinker™ on NittoPhase® Solid Support MOE MeC Succinate on Support A

Sequence: Isis MOE 5-10-5 GapmerBackbone: Phosphorothioate diesterLength: 20-mer Support Loading: 207 μmol/gSynthesizer: ÄKTA™ OligoPilot™100Column: 24 ml fixed bed columnSynthesis Scale: 1 mmol

Crude Full Length: 75%Purified Yield: 4.50 mg/μmolP=O: 1.7%N-1: 1.4%Shortmer: 1.6%Full Length: 95.8%Longmer: 2.5%

Sequence: Isis MOE 5-10-5 GapmerBackbone: Phosphorothioate diesterLength: 20-mer Support Loading: 201 μmol/gSynthesizer: ÄKTA™ OligoPilot™100Column: 24 ml fixed bed columnSynthesis Scale: 1 mmol

Crude Full Length: 74%Purified Yield: 3.99 mg/μmolP=O: 2.7%N-1: 0.8%Shortmer: 1.5%Full Length: 94.3%Longmer: 4.2%

Sequence: Isis 5-10-5 MOE GapmerBackbone: Phosphorothioate diesterLength: 20-mer Support Loading: 315 μmol/gSynthesizer: ÄKTA™ OligoProcess™

Column: TechniKrom® 60 cm (Asahi Kasei)

Synthesis Scale: 900 mmol Crude Full Length: 83%Crude Yield : 105 OD260/ μmol

Fig5.IPHPLCanalysisofcrudeoligonucleotide.

* Data Courtesy of Isis Pharmaceuticals, Inc.

Fig3.IP-HPLCanalysisofcrudeoligonucleotide.

Minutes

AU

260

0 5 10 15 20 25

0.10

0.20

0.30

0.40

30

AboutKinovateLifeSciences,Inc.Founded in 2004, Kinovate Life Sciences, Inc. has established itself as a leader in the field of solid supports for oligonucle-otide synthesis. Our manufacturing quality managment system has been developed to be fully compliant with ISO9001:2008. Our mission is to deliver the highest quality product at the most competitive price with the best customer service. Our commitment to these values has made us number one partner of choice for the industry’s solid support needs.